Octane Medical acquires B. Braun’s global orthobiologics business
our ventures
Our venture companies develop, validate and manufacture our innovations, then forge partnerships with global companies to bring our products to the international clinical market.
Novocart, a regenerative cartilage implant
2023
Partnered with our affiliate company TETEC AG (est. 2000)
Cocoon for automated production of cell therapies
2007
Partnered with Lonza Group.
Combines cutting-edge technology, deep ATMP expertise, and a strong global presence to redefine possibilities in personalized cell therapy and automation
2004
Seeking personalized therapy pioneers requiring an agile CDMO to safeguard every milestone from lab to market
High-throughput medical device production
2014
Partnered with Jubilant Life Sciences. Seeking partners for expanded product line opportunities.
Octane Exo Spinal implant, made with Octane HyperPEEK
2020
Seeking commercialization partners for Octane Exo Spinal and for other potential applications of Octane HyperPEEK.
AI driven Personalized bioelectric stimulation
2019
Developing early-stage ideas for proof-of-concept and subsequent transfer to a dedicated Octane champion who will drive the process towards the ultimate goal of commercialization through global partnerships.
